Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

PayPal Holdings, Inc. shares were down 1.2% at $58.38 in after-hours trading on Wednesday, when stocks changed hands outside the regular 9:30 a.m. to 4 p.m. ET session. The stock traded between $58.30 and $59.21 and saw about 13.0 million shares in volume, with the shares valued at roughly 13 times trailing earnings, a standard price-to-earnings measure.
Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05 to treat agitation linked to Alzheimer’s disease and granted it Priority Review. The agency set an April 30, 2026 target action date, and CEO Herriot Tabuteau said “up to 76% of people with Alzheimer’s disease experience agitation.” GlobeNewswire
Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

Pfizer Inc. shares fell about 0.4% to $24.90 in after-hours trading on Wednesday, after a report said the drugmaker is leading a wave of U.S. list-price increases set for 2026. The data, compiled by healthcare research firm 3 Axis Advisors, showed drugmakers plan hikes on at least 350 branded medicines, with Pfizer accounting for around 80 increases, including a 15% rise for its COVID vaccine Comirnaty. “They really just nibble around the margins,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital in Boston. Reuters
NASA Mars goes radio-silent as solar conjunction stalls MAVEN recovery efforts

NASA Mars goes radio-silent as solar conjunction stalls MAVEN recovery efforts

NASA has entered a planned communications blackout with its Mars missions as a solar alignment known as conjunction begins, delaying efforts to re-establish contact with the MAVEN orbiter that has been silent since early December, the agency said. NASA said the pause starts Dec. 29 and it does not expect contact with any Mars missions until Jan. 16. NASA Science
1 January 2026
Chili’s takes aim at McDonald’s value meals with $10.99 deal as diners balk at fast-food prices

Chili’s takes aim at McDonald’s value meals with $10.99 deal as diners balk at fast-food prices

Chili’s Grill & Bar took aim at McDonald’s, Wendy’s and Burger King on Wednesday, arguing that fast-food value meals no longer feel like a bargain and promoting its own $10.99 burger-and-sides deal. The post landed as McDonald’s CEO Chris Kempczinski told investors, “We continue to see a bifurcated consumer base,” a reference to spending splitting between higher- and lower-income diners. Fox News+1
1 617 618 619 620 621 893
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.